Obstet Gynecol Sci.  2020 Apr;63(3):286-292. 10.5468/ogs.2020.63.3.286.

Questionnaire survey on the management of pregnant women with preterm premature rupture of membranes

  • 1Division of Maternal and Fetal Medicine, Department of Obstetrics and Gynecology, Research Institute of Medical Science, Konkuk University, School of Medicine
  • 2Department of Obstetrics and Gynecology, Samsung medical Center, Sungkyunkwan University, School of Medicine
  • 3Department of Obstetrics and Gynecology, Konkuk University, School of Medicine
  • 4Department of Obstetrics and Gynecology, National Evidence-based Collaborating Agency; Department of Obstetrics and Gynecology
  • 5Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Seoul
  • 6Department of Obstetrics and Gynecology, Ajou University, School of Medicine, Suwon, Korea


The aim of this survey was to study the status of the actual practice in the management of preterm premature rupture of membranes (PPROM) between 34.0 and 36.6 weeks of gestation.
This survey was designed for obstetricians who work in secondary or tertiary medical institutions and attended the Korean Society of Maternal Fetal Medicine conference held on July 1, 2017, in Korea, using a structured questionnaire consisting of 5 questions.
The most commonly used antibiotic was cephalosporin monotherapy (34.5%). Antenatal corticosteroids were applied up to 34.0 weeks of gestation in half of the respondents. The frequency of expectant management was higher than that of immediate delivery in women with PPROM between 34.0 and 36.6 weeks of gestation (57.4%). The most important factor in determining immediate delivery was the symptoms of chorioamnionitis.
The present survey showed a considerable variation in the actual management of PPROM in women, especially the optimal timing of delivery. More evidenced-based studies with statistical power are required to decrease the heterogeneity of clinical practice.


Fetal membranes, premature rupture; Antibacterial agents; Betamethasone; Dexamethasone; Delivery, obstetric


  • Fig. 1 The preferred limit of gestation when corticosteroids were administered.

Cited by  1 articles

Detection of small for gestational age in preterm prelabor rupture of membranes by Hadlock versus the Fetal Medicine Foundation growth charts
Jose Duncan, Karla Leavitt, Kristin Duncan, Gustavo Vilchez
Obstet Gynecol Sci. 2021;64(3):248-256.    doi: 10.5468/ogs.20267.


1. Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin No. 188: prelabor rupture of membranes. Obstet Gynecol. 2018; 131:e1–14. PMID: 29266075.
2. Bond DM, Middleton P, Levett KM, van der Ham DP, Crowther CA, Buchanan SL, et al. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database Syst Rev. 2017; 3:CD004735. PMID: 28257562.
3. Chandra I, Sun L. Third trimester preterm and term premature rupture of membranes: is there any difference in maternal characteristics and pregnancy outcomes? J Chin Med Assoc. 2017; 80:657–661. PMID: 28431858.
4. Morris JM, Roberts CL, Bowen JR, Patterson JA, Bond DM, Algert CS, et al. Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet. 2016; 387:444–452. PMID: 26564381.
5. Ramsey PS, Nuthalapaty FS, Lu G, Ramin S, Nuthalapaty ES, Ramin KD. Contemporary management of preterm premature rupture of membranes (PPROM): a survey of maternal-fetal medicine providers. Am J Obstet Gynecol. 2004; 191:1497–1502. PMID: 15507990.
6. Goldenberg RL, Nelson KG, Davis RO, Koski J. Delay in delivery: influence of gestational age and the duration of delay on perinatal outcome. Obstet Gynecol. 1984; 64:480–484. PMID: 6483294.
7. Ekin A, Gezer C, Taner CE, Ozeren M, Uyar I, Gulhan I. Risk factors and perinatal outcomes associated with latency in preterm premature rupture of membranes between 24 and 34 weeks of gestation. Arch Gynecol Obstet. 2014; 290:449–455. PMID: 24695905.
8. Tsakiridis I, Mamopoulos A, Chalkia-Prapa EM, Athanasiadis A, Dagklis T. Preterm premature rupture of membranes: a review of 3 national guidelines. Obstet Gynecol Surv. 2018; 73:368–375. PMID: 29955897.
9. van Teeffelen AS, van der Ham DP, Willekes C, Al Nasiry S, Nijhuis JG, van Kuijk S, et al. Midtrimester preterm prelabour rupture of membranes (PPROM): expectant management or amnioinfusion for improving perinatal outcomes (PPROMEXIL - III trial). BMC Pregnancy Childbirth. 2014; 14:128. PMID: 24708702.
10. Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev. 2013; CD001058. PMID: 24297389.
11. American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics. Practice bulletin No. 172: premature rupture of membranes. Obstet Gynecol. 2016; 128:e165–77. PMID: 27661655.
12. Randis TM, Polin RA, Saade G. Chorioamnionitis: time for a new approach. Curr Opin Pediatr. 2017; 29:159–164. PMID: 28134708.
13. Siegel AM, Heine RP, Dotters-Katz SK. The effect of non-penicillin antibiotic regimens on neonatal outcomes in preterm premature rupture of membranes. AJP Rep. 2019; 9:e67–71. PMID: 30854246.
14. Buchanan SL, Crowther CA, Levett KM, Middleton P, Morris J. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database Syst Rev. 2010; CD004735. PMID: 20238332.
15. van der Ham DP, van der Heyden JL, Opmeer BC, Mulder AL, Moonen RM, van Beek JH, et al. Management of late-preterm premature rupture of membranes: the PPROMEXIL-2 trial. Am J Obstet Gynecol. 2012; 207:276.e1–276.10. PMID: 22901981.
Full Text Links
  • OGS
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr